寻找用于诊断恶性间皮瘤的最佳免疫组化组合。 - Suppr

Suppr

超能文献

The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma.

作者信息

Weiss L M, Battifora H

出版信息

Hum Pathol. 1993 Apr;24(4):345-6. doi: 10.1016/0046-8177(93)90079-v.

DOI:10.1016/0046-8177(93)90079-v

PMID:8491474

Abstract

摘要

相似文献

The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma.

Hum Pathol. 1993 Apr;24(4):345-6. doi: 10.1016/0046-8177(93)90079-v.

Differential immunohistochemical staining for retinoblastoma protein with the antibodies C15 and 1F8 in malignant mesothelioma.

Pathol Res Pract. 1994 Feb;190(2):138-41. doi: 10.1016/S0344-0338(11)80703-X.

[A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].

Pneumonol Alergol Pol. 2007;75(1):57-69.

Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma.

Cancer. 1991 Feb 1;67(3):655-62. doi: 10.1002/1097-0142(19910201)67:3<655::aid-cncr2820670322>3.0.co;2-j.

Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies.

Hum Pathol. 1994 Mar;25(3):227-34. doi: 10.1016/0046-8177(94)90192-9.

Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma.

Adv Anat Pathol. 2006 Nov;13(6):316-29. doi: 10.1097/01.pap.0000213064.05005.64.

Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.

Hum Pathol. 2013 Jan;44(1):1-19. doi: 10.1016/j.humpath.2012.05.014. Epub 2012 Sep 7.

Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.

Hum Pathol. 1993 Apr;24(4):347-54. doi: 10.1016/0046-8177(93)90080-z.

Primary malignant mesothelioma of the peritoneum: a clinical and immunohistochemical study.

Gynecol Oncol. 2005 Mar;96(3):860-4. doi: 10.1016/j.ygyno.2004.11.014.

The role of immunohistochemistry in the diagnosis of malignant mesothelioma.

Monaldi Arch Chest Dis. 1998 Apr;53(2):186-7.

引用本文的文献

Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.

J Clin Pathol. 2002 Sep;55(9):662-8. doi: 10.1136/jcp.55.9.662.

Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung.

Br J Cancer. 1998;77(2):260-9. doi: 10.1038/bjc.1998.42.

Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.

Am J Pathol. 1995 Feb;146(2):344-56.

OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.

J Clin Pathol. 1995 Jul;48(7):626-30. doi: 10.1136/jcp.48.7.626.

Malignant mesothelioma of the pleura: interobserver variability.

J Clin Pathol. 1995 Sep;48(9):856-60. doi: 10.1136/jcp.48.9.856.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验